Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCD researchers discover blood test to predict response to arthritis therapies

26.09.2007
UCD researchers have shown for the first time that a simple blood test can predict those patients suffering from inflammatory arthritis who will respond to treatment at an early stage.

The group of clinicians and scientists based in UCD Conway Institute of Biomolecular & Biomedical Research and St Vincent’s University Hospital, working with collaborators from McGill University, Montreal, have published their findings in the current issue of the leading scientific journal, Arthritis and Rheumatism.

Rheumatoid arthritis and psoriatic arthritis are forms of progressive inflammatory arthritis that cause pain and progressive destruction of the joints. These diseases can be treated using drugs called tumour necrosis factor alpha (TNFa) inhibitors, which prevent damage and limit disability in arthritis patients. The extent of joint destruction can be measured by x-ray but this visible progression develops over months and years and is not suitable to measure the efficiency of treatment to reduce joint damage over a short period.

Dr Ronan Mullan, a medical PhD student with the arthritis translational research group led by Professor Douglas Veale and Dr Ursula Fearon, funded by The Health Research Board and Science Foundation Ireland, outlined the findings of this clinical study that measured particles of cartilage collagen in the blood after the start of treatment with anti-TNFa drugs. The early changes seen in the blood levels of these collagen biomarkers at 4 weeks corresponded to the visible joint destruction seen on x-ray after one year.

‘We are very excited about the results of this research, which clearly show that collagen biomarkers may be valuable early indicators of response to arthritis treatment’, said Professor Douglas Veale. ‘This new blood test could rapidly identify patients who are at risk of their disease progressing despite ongoing therapy. It would be a valuable diagnostic tool for clinicians’.

Rheumatoid arthritis is the most widespread form of inflammatory arthritis affecting more than 80,000 people in Ireland today. It can severely impact on the quality of life of patients and direct medical costs have been estimated at €30,000 per annum for each patient. An early indicator of likely response to new and expensive treatments would not only benefit the patient but the health service generally.

This research group led by Professor Douglas Veale and Dr Ursula Fearon are part of the newly formed, Dublin Academic Health Care (DAHC); Ireland’s first academic medical centre.

Elaine Quinn | alfa
Further information:
http://www.ucd.ie
http://www3.interscience.wiley.com/cgi-bin/abstract/116311017/ABSTRACT?CRETRY=1&SRETRY=0

Further reports about: Arthritis Collagen Treatment Veale destruction inflammatory

More articles from Life Sciences:

nachricht Scientists decipher key principle behind reaction of metalloenzymes
15.01.2018 | Rheinisch-Westfälische Technische Hochschule Aachen

nachricht New method to map miniature brain circuits
15.01.2018 | The Francis Crick Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

Im Focus: Autoimmune Reaction Successfully Halted in Early Stage Islet Autoimmunity

Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.

Type 1 diabetes is the most common metabolic disease in childhood and adolescence. In this disease, the body's own immune system attacks and destroys the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fachtagung analytica conference 2018

15.01.2018 | Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

 
Latest News

Black hole spin cranks-up radio volume

15.01.2018 | Physics and Astronomy

A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

15.01.2018 | Life Sciences

New method to map miniature brain circuits

15.01.2018 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>